PRESENTED BY-DR. BISWAJEETA SAHA, DEPT OF PATHOLOGY
                                            KIMS,BBSR
Introduction
 2006 AHA defined cardiomyopathies as “a heterogeneous group of
  diseases of the myocardium associated with mechanical &/or electrical
  dysfunction that usually (but not invariably) exhibit inappropriate
  ventricular hypertrophy or dilatation and are due to a variety of causes

  that frequently are genetic.”




 Cardiomyopathies either are confined to the heart or are a part of
  generalized systemic disorders
Functional classification


 Dilated cardiomyopathy

 Hypertrophic cardiomyopathy

 Restrictive cardiomyopathy

 Arrhthymogenic Right Ventricular disease(ARVD)
DILATED
CARDIOMYOPATHY
Definition



 Primary (idiopathic) is a disease of unknown etiology that principally
  affects the myocardium leading to LV dilation and systolic dysfunction



 Most common of the cardiomyopathies
Causes
 Genetic influences-

 20-50% are familial

 Autosomal dominant –predominant pattern

 Mutations in genes encoding dystrophin,δ sarcoglycan,troponin T,β
  MHC etc

 Myocarditis

 Alcohol and other toxins

 Childbirth (peripartum cardiomyopathy)
Morphology
 Heart enlarged,heavy,flabby

 Mural thrombi common

 Dilatation of all chambers,both ventricular hypertrophy

 Microscopically-atrophic and hypertrophic myocardial fibres,cardiac
  myocytes show degenerative changes

 Interstitial and endocardial fibrosis
Clinical features-
 Highest incidence in middle age
 Symptoms may be gradual in onset
 Acute presentation
    Misdiagnosed as viral URI in young adults
 Symptoms/Signs of heart failure
    Pulmonary congestion (left heart failure)
     dyspnea (rest, exertional, nocturnal), orthopnea
    Systemic congestion (right heart failure)
     edema, nausea, abdominal pain, nocturia
    Low cardiac output
    Hypotension, tachycardia, tachypnea
    Fatigue and weakness
 Arrhythmia
    Atrial fibrillation, conduction delays,,sudden death
DCM - Incidence and Prognosis

 Prevalence is 36 per 100,000 population

 Third most common cause of heart failure

 Most frequent cause of heart transplantation

 Complete recovery is rare

 50% die within 2yrs and 25% survive longer than 5yrs
HYPERTOPHIC
CARDIOMYOPATHY
Hypertrophic cardiomyopathy


 Characterised by myocardial hypertrophy,abnormal diastolic
  filling,intermittent ventricular outflow obstruction

 Related to defects in force generation owing to altered sarcomeric
  function

 Leading cause of LVH,unexplained by other clinical/pathologic cause

 Caused by mutation of genes encoding sarcomeric proteins
Pathogenesis

 Autosomal dominant with variable penetrance

 Remaining are sporadic

 Mutations are mostly missense

 Mutations causing HCM found in genes encoding β MHC,cardiac
  TnT,α tropomyosin,myosin binding protein C
 The major abnormality of the heart
  in HCM -- excessive thickening of
  the muscle. Thickening usually
  begins during early adolescence and
  stops when growth has finished.
  uncommon for thickening to
  progress after this age

 left ventricle almost always affected

 Hypertrophy is usually greatest in
  the septum, associated with
  obstruction to the flow of blood into
  the aorta
 Asymmetric septal
  hypertrophy with obstruction
  to the outflow of blood from
  the heart may occur. The mitral
  valve touches the septum,
  blocking the outflow tract.
  Some blood is leaking back
  through the mitral valve
  causing mitral regurgitation
Histologic features
 Extensive myocyte
  hypertrophy



 Myofiber disarray



 Interstitial and
  replacement
  fibrosis
Pathophysiology

 Impaired diastolic filling-----reduced stroke volume

 Reduced CO and increase in pulm venous pressure---exertional
  dyspneoa

 Diastolic dysfunction

    Impaired diastolic filling,   filling pressure

 Myocardial ischemia

 Mitral regurgitation

 Arrhythmias
Clinical features

 Asymptomatic
    Echocardiographic finding only


 Symptomatic
    Dyspnea in 90%
    Harsh systolic ejection murmur
    Angina pectoris in 75%
    Fatigue, pre-syncope, syncope, risk of SCD
    Palpitation, PND, CHF, dizziness
    Atrial fibrillation, thromboembolism
RESTRICTIVE
CARDIOMYOPATHY
Restrictive cardiomyopathy


 Hallmark: abnormal diastolic function

 Rigid ventricular wall with impaired ventricular filling ,contractile
  functions are normal

 Much less common then DCM or HCM

 Characterised by primary disease in ventricular compliance resulting in
  impaired ventricular filing during diastole
CAUSES

 Primary---idiopathic



 Associated with –

 Radiation fibrosis

 Amyloidosis

 Sarcoidosis

 Metastatic tumors

 Metabolic deposition diseases
Morphology

 Ventricles are of normal size

 Cavities are not dilated

 Myocardium is firm and non compliant

 Biatrial dilatation is common

 Patchy/diffuse interstitial fibrosis
Clinical manifestations

• Symptoms of right and left heart failure

• Echo-Doppler
  – Abnormal mitral inflow pattern

  -Prominent E wave (rapid diastolic filling)

   Almost invariably progresses to congestive heart failure,10% survive

     for 10 yrs
Amyloidosis
               Cardiac enlargement without
                ventricular dilatation

               Ventricular walls are thickened
                and rubbery

               Amyloid deposition is most
                prominent in
                interstitial,perivascular and
                endocardial regions
Endomyocardial diseases
 Endomyocardial fibrosis    Loefflers endomyocarditis
hemochromatosis




                  sarcoidosis
Fabrys disease




         Pompes disease
Arrythmogenic right ventricular
cardiomyopathy
 Inherited disease of cardiac muscle
 RVF,rhytm disturbances,ventricular tachycardia,fibrillation
 Rt ventricular wall is thinned,extensive fatty infiltration and fibrosis
 Autosomal dominant inheritence
THANK YOU

Cardiomyopathies

  • 1.
    PRESENTED BY-DR. BISWAJEETASAHA, DEPT OF PATHOLOGY KIMS,BBSR
  • 2.
    Introduction  2006 AHAdefined cardiomyopathies as “a heterogeneous group of diseases of the myocardium associated with mechanical &/or electrical dysfunction that usually (but not invariably) exhibit inappropriate ventricular hypertrophy or dilatation and are due to a variety of causes that frequently are genetic.”  Cardiomyopathies either are confined to the heart or are a part of generalized systemic disorders
  • 3.
    Functional classification  Dilatedcardiomyopathy  Hypertrophic cardiomyopathy  Restrictive cardiomyopathy  Arrhthymogenic Right Ventricular disease(ARVD)
  • 4.
  • 5.
    Definition  Primary (idiopathic)is a disease of unknown etiology that principally affects the myocardium leading to LV dilation and systolic dysfunction  Most common of the cardiomyopathies
  • 6.
    Causes  Genetic influences- 20-50% are familial  Autosomal dominant –predominant pattern  Mutations in genes encoding dystrophin,δ sarcoglycan,troponin T,β MHC etc  Myocarditis  Alcohol and other toxins  Childbirth (peripartum cardiomyopathy)
  • 9.
    Morphology  Heart enlarged,heavy,flabby Mural thrombi common  Dilatation of all chambers,both ventricular hypertrophy  Microscopically-atrophic and hypertrophic myocardial fibres,cardiac myocytes show degenerative changes  Interstitial and endocardial fibrosis
  • 10.
    Clinical features-  Highestincidence in middle age  Symptoms may be gradual in onset  Acute presentation  Misdiagnosed as viral URI in young adults  Symptoms/Signs of heart failure  Pulmonary congestion (left heart failure) dyspnea (rest, exertional, nocturnal), orthopnea  Systemic congestion (right heart failure) edema, nausea, abdominal pain, nocturia  Low cardiac output  Hypotension, tachycardia, tachypnea  Fatigue and weakness  Arrhythmia  Atrial fibrillation, conduction delays,,sudden death
  • 12.
    DCM - Incidenceand Prognosis  Prevalence is 36 per 100,000 population  Third most common cause of heart failure  Most frequent cause of heart transplantation  Complete recovery is rare  50% die within 2yrs and 25% survive longer than 5yrs
  • 13.
  • 14.
    Hypertrophic cardiomyopathy  Characterisedby myocardial hypertrophy,abnormal diastolic filling,intermittent ventricular outflow obstruction  Related to defects in force generation owing to altered sarcomeric function  Leading cause of LVH,unexplained by other clinical/pathologic cause  Caused by mutation of genes encoding sarcomeric proteins
  • 15.
    Pathogenesis  Autosomal dominantwith variable penetrance  Remaining are sporadic  Mutations are mostly missense  Mutations causing HCM found in genes encoding β MHC,cardiac TnT,α tropomyosin,myosin binding protein C
  • 16.
     The majorabnormality of the heart in HCM -- excessive thickening of the muscle. Thickening usually begins during early adolescence and stops when growth has finished. uncommon for thickening to progress after this age  left ventricle almost always affected  Hypertrophy is usually greatest in the septum, associated with obstruction to the flow of blood into the aorta
  • 17.
     Asymmetric septal hypertrophy with obstruction to the outflow of blood from the heart may occur. The mitral valve touches the septum, blocking the outflow tract. Some blood is leaking back through the mitral valve causing mitral regurgitation
  • 18.
    Histologic features  Extensivemyocyte hypertrophy  Myofiber disarray  Interstitial and replacement fibrosis
  • 19.
    Pathophysiology  Impaired diastolicfilling-----reduced stroke volume  Reduced CO and increase in pulm venous pressure---exertional dyspneoa  Diastolic dysfunction  Impaired diastolic filling, filling pressure  Myocardial ischemia  Mitral regurgitation  Arrhythmias
  • 20.
    Clinical features  Asymptomatic  Echocardiographic finding only  Symptomatic  Dyspnea in 90%  Harsh systolic ejection murmur  Angina pectoris in 75%  Fatigue, pre-syncope, syncope, risk of SCD  Palpitation, PND, CHF, dizziness  Atrial fibrillation, thromboembolism
  • 21.
  • 22.
    Restrictive cardiomyopathy  Hallmark:abnormal diastolic function  Rigid ventricular wall with impaired ventricular filling ,contractile functions are normal  Much less common then DCM or HCM  Characterised by primary disease in ventricular compliance resulting in impaired ventricular filing during diastole
  • 23.
    CAUSES  Primary---idiopathic  Associatedwith –  Radiation fibrosis  Amyloidosis  Sarcoidosis  Metastatic tumors  Metabolic deposition diseases
  • 24.
    Morphology  Ventricles areof normal size  Cavities are not dilated  Myocardium is firm and non compliant  Biatrial dilatation is common  Patchy/diffuse interstitial fibrosis
  • 25.
    Clinical manifestations • Symptomsof right and left heart failure • Echo-Doppler – Abnormal mitral inflow pattern -Prominent E wave (rapid diastolic filling)  Almost invariably progresses to congestive heart failure,10% survive for 10 yrs
  • 26.
    Amyloidosis  Cardiac enlargement without ventricular dilatation  Ventricular walls are thickened and rubbery  Amyloid deposition is most prominent in interstitial,perivascular and endocardial regions
  • 27.
    Endomyocardial diseases  Endomyocardialfibrosis  Loefflers endomyocarditis
  • 28.
    hemochromatosis sarcoidosis
  • 29.
    Fabrys disease Pompes disease
  • 30.
    Arrythmogenic right ventricular cardiomyopathy Inherited disease of cardiac muscle  RVF,rhytm disturbances,ventricular tachycardia,fibrillation  Rt ventricular wall is thinned,extensive fatty infiltration and fibrosis  Autosomal dominant inheritence
  • 31.